C4 Therapeutics Q1 2026 Earnings EPS Surprises to the Upside as Biotech Focuses on Pipeline Execution Unity Software Q1 2026 Earnings Narrowed Loss Exceeds Expectations PFSI Q1 2026 Earnings EPS Misses Estimates Amid Challenging Environment Catalyst Pharmaceuticals CPRX Q1 2026 Earnings EPS Beat Signals Operational Strength Amid Quiet Revenue Reporting ROKU Q1 2026 Earnings EPS Surges Past Estimates with 71 Beat